Question 14

Mercaptopurine is considered to be high-alert in a community pharmacy setting.

Mercaptopurine is recognized as a high-alert medication due to its potential for severe adverse effects and its use in the treatment of certain cancers and autoimmune diseases, requiring careful monitoring and dosage adjustments.

A) Meloxicam

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to relieve pain and inflammation. While it carries risks, particularly for gastrointestinal and cardiovascular effects, it is not classified as a high-alert medication, as it is generally considered safer compared to chemotherapeutic agents.

B) Mercaptopurine

Mercaptopurine is a cytotoxic medication used primarily in the treatment of leukemia and other malignancies. It is considered high-alert due to the risk of significant toxicity, including bone marrow suppression, and the necessity for careful dosage management, making it critical to ensure its safe handling in a community pharmacy setting.

C) Metronidazole

Metronidazole is an antibiotic used to treat various infections, including those caused by anaerobic bacteria and protozoa. Although it has some side effects, it is not categorized as high-alert due to its more manageable safety profile compared to medications like mercaptopurine.

D) Methocarbamol

Methocarbamol is a muscle relaxant used to treat muscle spasms and discomfort. It is not considered a high-alert medication, as its potential side effects are generally mild and manageable, thus not warranting the same level of caution as mercaptopurine.

Conclusion

Mercaptopurine stands out as the only high-alert medication among the options due to its significant risk of severe adverse effects and the critical need for careful monitoring. In contrast, the other medications listed, while they do have risks, do not pose the same level of danger and complexity in management, confirming mercaptopurine's unique status in a community pharmacy setting.